Robert Galamaga, DO, MS

Barrow Oncology is a full-service, complete cancer care team that allows patients with benign and malignant tumors to have all of their oncological services provided and coordinated in the same center. We offer a multidisciplinary team of neurosurgeons, head and neck surgeons, medical oncologists, neuro-oncologists, speech-language pathologists, ENT specialists, and radiation oncologists offering the latest treatment for head and neck cancer, neurological cancers, and metastatic cancers.

Ameya A. Jategaonkar, MD, is an otolaryngologist in the Department of ENT and skull base surgery at Barrow Neurological Institute. Dr. Jategaonkar specializes in the surgical treatment of head and neck cancers, transoral robotic surgery, thyroid and parathyroid surgery, open skull base surgery, and microvascular reconstructive surgery of the head and neck. He is a member of the American Academy of Otolaryngology—Head and Neck Surgery and the American Head and Neck Society. Dr. Jategaonkar earned his medical degree from the University of Arizona College of Medicine—Phoenix. He completed his otolaryngology residency at Icahn School of Medicine at Mount Sinai in New York City and a fellowship in advanced head and neck oncologic and microvascular reconstructive surgery at Thomas Jefferson University in Philadelphia. Dr. Jategaonkar’s clinical research interests include expanding minimally invasive/transoral techniques for treating head and neck cancers and optimizing techniques and outcomes for microvascular free tissue transfer in head and neck reconstruction.

Joyce K. Lee-Iannotti, MD, FAAN, FAASM, is the interim director of the Petznick Stroke Center and the inaugural director of the Sleep Division at Barrow Neurological Institute, as well as a professor of neurology at both the Institute and the University of Arizona College of Medicine—Phoenix. She is board certified in general neurology, vascular neurology, and sleep medicine by the American Board of Psychiatry and Neurology. Additionally, she holds a certification in the interpretation of transcranial Doppler ultrasound for neurovascular diseases from the American Society of Neuroimaging. Dr. Lee-Iannotti’s expertise includes the diagnosis and treatment of neurovascular diseases and sleep disorders, with a particular specialty in central disorders of hypersomnia (e.g. narcolepsy), REM sleep behavior disorder, and sleep-wake disturbances in long COVID. She is a fellow of the American Academy of Neurology (AAN) and chair of its Sleep Section. She is also a fellow of the American Academy of Sleep Medicine (AASM). Within the AASM, she is the chair of the Sleep Medicine Fellowship Directors Council Steering Committee, a member of the AASM Advocacy Committee, and a task force member of the AASM Focused Update on Diagnostic Testing for Adult Obstructive Sleep Apnea Guidelines. Additionally, she directs the AASM Board of Directors and the AASM Foundation Board of Directors. Dr. Lee-Iannotti earned her medical degree from the University of South Carolina School of Medicine in Columbia. She completed both her neurology residency and a sleep medicine fellowship at Cleveland Clinic Foundation in Ohio. She also completed a fellowship in stroke and cerebrovascular diseases at Mayo Clinic in Arizona. Dr. Lee-Iannotti’s research interests include REM sleep behavior disorder, narcolepsy, neuro-COVID syndromes, and the intersection of sleep apnea and stroke. She is also deeply engaged in medical education and advocacy.